Literature DB >> 6497132

Dexamethasone and prednisolone in the horse: pharmacokinetics and action on the adrenal gland.

P L Toutain, R A Brandon, H de Pomyers, M Alvinerie, J D Baggot.   

Abstract

Pharmacokinetics of dexamethasone and prednisolone were studied in 6 horses given dexamethasone alcohol (IV or IM) or dexamethasone 21-isonicotinate as a solution IV or IM (50 micrograms/kg of body weight), prednisolone 21-sodium succinate IV or IM (0.6 mg/kg of body weight), or prednisolone acetate IM (0.6 mg/kg of body weight). Plasma concentrations were determined using a high-performance liquid chromatographic method. After dexamethasone alcohol (IV) or dexamethasone 21-isonicotinate (IV), the half-life of elimination was similar (53 minutes) for both formulations. After dexamethasone (alcohol and isonicotinate, IM), concentrations were low or nondetected. After prednisolone 21-sodium succinate (IV), the half-life of elimination (99.5 minutes) was significantly (P less than 0.01) longer than that for dexamethasone. After prednisolone 21-sodium succinate (IM), absorption was rapid and bioavailability was high. After prednisolone acetate (IM), absorption was slow and prednisolone was present in plasma for about 7 days. Due to the nonlinearity of prednisolone kinetics, a bioavailability higher than 100% was obtained. The basal plasma hydrocortisone concentration was approximately 70 ng/ml. After dexamethasone (IV or IM), plasma hydrocortisone values decreased after a 2-hour delay and returned to base line after a 3 to 4 day delay. After prednisolone 21-sodium succinate (IV or IM), plasma hydrocortisone decreased immediately (IV) or rapidly (IM) and returned to base line after a 24-hour delay. After prednisolone acetate (IM), plasma hydrocortisone decreased for up to 21 days.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6497132

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  9 in total

1.  Electroacupuncture in the treatment of chronic lameness in horses and ponies: a controlled clinical trial.

Authors:  J E Steiss; N A White; J M Bowen
Journal:  Can J Vet Res       Date:  1989-04       Impact factor: 1.310

2.  Effects of dexamethasone on selected parameters of the bovine immune system.

Authors:  J H Pruett; W F Fisher; J R DeLoach
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

3.  Pharmacokinetics and pharmacodynamics of dexamethasone after intravenous administration in camels: effect of dose.

Authors:  N A Al Katheeri; I A Wasfi; M Lambert; A Saeed
Journal:  Vet Res Commun       Date:  2004-08       Impact factor: 2.459

4.  Distinct actions of prednisolone and dexamethasone towards osteocalcin and eosinophilic cationic protein in assumed clinically equivalent doses: a study in healthy men.

Authors:  E F L Dubois; M G M Derks; A H Zwinderman; P N R Dekhuijzen; C J Van Boxtel; D H Schweitzer
Journal:  Eur J Clin Pharmacol       Date:  2003-02-15       Impact factor: 2.953

5.  Across-species meta-analysis of dexamethasone pharmacokinetics utilizing allometric and scaling modeling approaches.

Authors:  Dawei Song; William J Jusko
Journal:  Biopharm Drug Dispos       Date:  2021-03-17       Impact factor: 1.627

6.  Modelling of oscillatory cortisol response in horses using a Bayesian population approach for evaluation of dexamethasone suppression test protocols.

Authors:  Felix Held; Carl Ekstrand; Marija Cvijovic; Johan Gabrielsson; Mats Jirstrand
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-01-23       Impact factor: 2.745

7.  Real-time analysis of gene regulation by glucocorticoid hormones.

Authors:  A McMaster; T Chambers; Q-J Meng; S Grundy; A S I Loudon; R Donn; D W Ray
Journal:  J Endocrinol       Date:  2008-05       Impact factor: 4.286

8.  Plasma and ocular prednisolone disposition after oral treatment in cats.

Authors:  María J Del Sole; Paula Schaiquevich; Marcelo A Aba; Carlos E Lanusse; Laura Moreno
Journal:  Biomed Res Int       Date:  2013-08-29       Impact factor: 3.411

9.  Prednisolone in Dogs-Plasma Exposure and White Blood Cell Response.

Authors:  Carl Ekstrand; Helena Pettersson; Ronette Gehring; Mikael Hedeland; Sara Adolfsson; Inger Lilliehöök
Journal:  Front Vet Sci       Date:  2021-06-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.